19 October 2026
strategyland.uk
Bridgepoint Group PLC (BPTB)
Rank #176 of 280 - Financials - UK Equities
Bridgepoint Group PLC
Factor Analysis Summary
Editorial assessment generated from Bridgepoint Group PLC's live factor scores and sector positioning.
Based on Strategyland's proprietary 7-factor analysis, Bridgepoint Group PLC (BPTB.L) currently holds an overall rank of #176 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.
Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit, and market trading, where it demonstrates healthy trading activity and market interest relative to the FTSE 100 median.
Areas requiring attention include asset efficiency, where poor capital efficiency suggests assets may be underutilised or overvalued on the balance sheet, as well as valuation (P/E 135.4, dividend yield 542.5%), where the stock appears richly priced on forward earnings and cash flow metrics.
Within the Financials sector, Bridgepoint Group PLC sits at composite rank #176, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.
The composite profile is weighed down by 4 below-average factor scores, with asset efficiency (rank 273/280) representing the most significant drag on its #176 overall standing.
Strongest Factors
- Liquidity — Rank 69/280 (top quartile)
- Market Trading — Rank 87/280 (above average)
- Technical — Rank 126/280 (middle of the pack)
Weakest Factors
- Asset Efficiency — Rank 273/280 (below average)
- Valuation — Rank 236/280 (below average)
Score Analysis
Bridgepoint Group PLC is ranked #176 out of 280 UK stocks. Lower factor scores indicate better performance in that category.
Factor Breakdown
1. Liquidity
Score: 69/280How liquid is BPTB and can it meet its short-term obligations?
Key Liquidity Metrics
Overall Liquidity Rank
2. Valuation
Score: 236/280Is BPTB undervalued compared to its peers and fair value metrics?
Key Valuation Metrics
Dividend
BPTB pays a dividend yield of 542.53%.
Dividend Per Share Forecast
3. Profitability
Score: 227/280How profitable is BPTB relative to its peers?
EPS Growth
4. Solvency
Score: 195/280How strong is BPTB's balance sheet and financial position?
Key Solvency Metrics
Altman Z-Score
5. Asset Efficiency
Score: 273/280How efficiently does BPTB deploy its assets and intellectual capital?
Overall Asset Efficiency Rank
6. Market Trading
Score: 87/280How liquid and actively traded is BPTB?
Trading Volume
7. Technical
Score: 126/280What do the technical indicators say about BPTB?
RSI (14 Day)
Moving Averages
Risk Metrics
Peer Comparison
How does BPTB compare to other Financials stocks?
Overall Rank Comparison
Factor Score Comparison
Similar Stocks
Other top-ranked stocks in the Financials sector
LiveCatch Healthcare Events Before the Market Moves
SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.
Methodology Note
The analysis presented for Bridgepoint Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.
Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.
This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.
© 2026 Strategyland by Khurram. All rights reserved.
